Warfarin for stroke prevention in atrial fibrillation: time to switch?

被引：3

作者：

Ahmad, Y. ^{[1
]}

Lip, G. Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England

来源：

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2013年 / 67卷 / 07期

关键词：

DABIGATRAN ETEXILATE; MANAGEMENT; THERAPY;

D O I：

10.1111/ijcp.12157

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：603 / 605

页数：3

共 11 条

[1]

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance [J].

Ahmad, Yousif ;

Lip, Gregory Y. H. .

HEART, 2012, 98 (19) :1404-1406

[2]

Barcellona D, 2000, THROMB HAEMOSTASIS, V83, P49

[3]

Camm AJ, 2012, EUR HEART J, V33

[4]

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2006 WRITING COMMITTEE MEMBERS Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [J].

Fuster, Valentin ;

Ryden, Lars E. ;

Cannom, Davis S. ;

Crijns, Harry J. ;

Curtis, Anne B. ;

Ellenbogen, Kenneth A. ;

Halperin, Jonathan L. ;

Kay, G. Neal ;

Le Huezey, Jean-Yves ;

Lowe, James E. ;

Olsson, S. Bertil ;

Prystowsky, Eric N. ;

Tamargo, Juan Luis ;

Wann, L. Samuel ;

Estes, N. A. Mark, III ;

Ezekowitz, Michael D. ;

Jackman, Warren M. ;

January, Craig T. ;

Page, Richard L. ;

Slotwiner, David J. ;

Stevenson, William G. ;

Tracy, Cynthia M. ;

Jacobs, Alice K. ;

Anderson, Jeffrey L. ;

Albert, Nancy ;

Buller, Christopher E. ;

Creager, Mark A. ;

Ettinger, Steven M. ;

Guyton, Robert A. ;

Hochman, Judith S. ;

Kushner, Frederick G. ;

Ohman, Erik Magnus ;

Tarkington, Lynn G. ;

Yancy, Clyde W. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (11) :E101-E198

[5]

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients [J].

Gallagher, Arlene M. ;

Setakis, Efrosini ;

Plumb, Jonathan M. ;

Clemens, Andreas ;

van Staa, Tjeerd-Pieter .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) :968-977

[6]

Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].

Hart, Robert G. ;

Pearce, Lesly A. ;

Aguilar, Maria I. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867

[7]

Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice [J].

Huisman, Menno V. ;

Lip, Gregory Y. H. ;

Diener, Hans-Christoph ;

Brueckmann, Martina ;

van Ryn, Joanne ;

Clemens, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (05) :838-847

[8]

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: A nationwide cohort study [J].

Olesen, Jonas Bjerring ;

Torp-Pedersen, Christian ;

Hansen, Morten Lock ;

Lip, Gregory Y. H. .

THROMBOSIS AND HAEMOSTASIS, 2012, 107 (06) :1172-1179

[9]

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control [J].

Skanes, Allan C. ;

Healey, Jeff S. ;

Cairns, John A. ;

Dorian, Paul ;

Gillis, Anne M. ;

McMurtry, M. Sean ;

Mitchell, L. Brent ;

Verma, Atul ;

Nattel, Stanley .

CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (02) :125-136

[10]

Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor [J].

Turpie, Alexander G. G. ;

Kreutz, Reinhold ;

Llau, Juan ;

Norrving, Bo ;

Haas, Sylvia .

THROMBOSIS AND HAEMOSTASIS, 2012, 108 (05) :876-886

← 1 2 →